Cargando…

Antiprogestins in gynecological diseases

Antiprogestins constitute a group of compounds, developed since the early 1980s, that bind progesterone receptors with different affinities. The first clinical uses for antiprogestins were in reproductive medicine, e.g., menstrual regulation, emergency contraception, and termination of early pregnan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goyeneche, Alicia A, Telleria, Carlos M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247796/ https://www.ncbi.nlm.nih.gov/pubmed/25252652 http://dx.doi.org/10.1530/REP-14-0416

Ejemplares similares

Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
por: Gamarra-Luques, Carlos D, et al.
Publicado: (2014)

Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2
por: Goyeneche, Alicia A., et al.
Publicado: (2011)

Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression
por: Tieszen, Chelsea R, et al.
Publicado: (2011)

New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach
por: Woźniczka, Magdalena, et al.
Publicado: (2021)

Exogenous estradiol enhances apoptosis in regressing post-partum rat corpora lutea possibly mediated by prolactin
por: Goyeneche, Alicia A, et al.
Publicado: (2005)

Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
por: Goyeneche, Alicia A, et al.
Publicado: (2012)

Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
por: Bartlett, Thomas E., et al.
Publicado: (2022)

Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
por: Bartlett, Thomas E., et al.
Publicado: (2022)

High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
por: Lisio, Michael-Antony, et al.
Publicado: (2019)

Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin
por: Kapperman, Heather E., et al.
Publicado: (2018)

The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone
por: Ritch, Sabrina J., et al.
Publicado: (2022)

Long-term primary culture of a clear cell ovarian carcinoma reveals an epithelial–mesenchymal cooperative interaction
por: Goyeneche, Alicia A., et al.
Publicado: (2015)

Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
por: Freeburg, Elizabeth M, et al.
Publicado: (2009)

Advanced assessment of migration and invasion of cancer cells in response to mifepristone therapy using double fluorescence cytochemical labeling
por: Ritch, Sabrina J., et al.
Publicado: (2019)

The Capacity of High-Grade Serous Ovarian Cancer Cells to Form Multicellular Structures Spontaneously along Disease Progression Correlates with Their Orthotopic Tumorigenicity in Immunosuppressed Mice
por: Goyeneche, Alicia, et al.
Publicado: (2020)

Anticancer effects of mifepristone on human uveal melanoma cells
por: Alvarez, Prisca Bustamante, et al.
Publicado: (2021)

Nelfinavir Induces Cytotoxicity towards High-Grade Serous Ovarian Cancer Cells, Involving Induction of the Unfolded Protein Response, Modulation of Protein Synthesis, DNA Damage, Lysosomal Impairment, and Potentiation of Toxicity Caused by Proteasome Inhibition
por: Subeha, Mahbuba R., et al.
Publicado: (2021)

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
por: Cottu, Paul H., et al.
Publicado: (2018)

Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics
por: Brandhagen, BreeAnn N, et al.
Publicado: (2013)

Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells
por: Abdalbari, Farah H., et al.
Publicado: (2023)

Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER(+ )breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim
por: Periyasamy-Thandavan, Sudharsan, et al.
Publicado: (2012)

Prevention of Diseases in Gynecology
por: Izetbegovic, Sebija, et al.
Publicado: (2013)

Nutrition in Gynecological Diseases: Current Perspectives
por: Ciebiera, Michał, et al.
Publicado: (2021)

The Role of Iron and Cobalt in Gynecological Diseases
por: Ćwiertnia, Adrianna, et al.
Publicado: (2022)

Syllabus of Gynecology, Based on the American Text-Book of Gynecology
Publicado: (1895)

Manual of Gynecology
Publicado: (1882)

Surgery and Gynecology
Publicado: (1911)

Lessons in Gynecology
Publicado: (1889)

Lessons in Gynecology
Publicado: (1880)

Manual of Gynecology
Publicado: (1883)

Gynecologic cancer
por: Mead, G. M.
Publicado: (1985)

Photodynamic Therapy for Gynecological Diseases and Breast Cancer
por: Shishkova, Natashis, et al.
Publicado: (2012)

Practical Gynecology: A Handbook on the Diseases of Women
Publicado: (1878)

Celiac disease and obstetrical-gynecological contribution
por: Casella, Giovanni, et al.
Publicado: (2016)

A mini-review of aesthetic gynecology and leading gynecology associations’ approaches to this issue
por: Güneş, Aylin, et al.
Publicado: (2018)

Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention
por: Tindale, Lauren C., et al.
Publicado: (2022)

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
por: Subeha, Mahbuba R., et al.
Publicado: (2020)

Comorbidity of gynecological and non-gynecological diseases with adenomyosis and endometriosis
por: Choi, Eun Ji, et al.
Publicado: (2017)

GYNECOLOGIC CYTOPATHOLOGY
Publicado: (1979)

Practical Gynecology
Publicado: (1950)

Cannot write session to /tmp/vufind_sessions/sess_qng1e8ot5if7tj6sr8cfk434t4